BSoD-10_White Biotech - New Strategies in Big Pharma

BSoD-10_White Biotech - New Strategies in Big Pharma

This seminar reveals current strategies of global players for successfull implementation
of biocatalysis and fermentation to achieve higher yield and more sustainability with new
innvations in biotech.

More details


9,99 € tax incl.

BSoD-10

Online only

Industrial Biotechnology is made up by different sectors: red biotech (diagnostics, 
pharmaceuticals), green biotech (production of agents in plants) and white biotech
(use of alternative resources, smaller plants with higher efficiency). White biotech
becomes more and more attractive to pharmaceutical companies by delivering
potential for new multi-product facilities instead of conventional petrochemical processes
requiring high physical parameters such as temperature and pressure.

Prospective project managers dealing with white biotech processes face the current
challenge between new pure-play white biotech procedures and conventional synthetic
manufacturing.